Sodium Aurothiomalate is a disease-modifying antirheumatic drug (DMARD) used in the management of rheumatoid arthritis and related inflammatory conditions. This gold-containing compound functions by modifying… Read more
Sodium Aurothiomalate is a disease-modifying antirheumatic drug (DMARD) used in the management of rheumatoid arthritis and related inflammatory conditions. This gold-containing compound functions by modifying the disease process rather than merely alleviating symptoms, necessitating rigorous quality control during manufacturing and development. Pharmaceutical laboratories utilize this collection of reference standards, including the active pharmaceutical ingredient (API), pharmacopeial and non-pharmacopeial impurities, and stable isotope labelled compounds, to support essential analytical testing. High-purity reference materials are critical for accurate impurity profiling and method validation, ensuring that analytical methods can reliably detect and quantify degradation products or process-related impurities. By incorporating these labelled standards as internal standards in mass spectrometry workflows, researchers can improve the precision of their assays, ultimately maintaining compliance with regulatory standards for drug quality and safety throughout the pharmaceutical lifecycle.